| Product Code: ETC6755121 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Therapeutic Vaccines Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Therapeutic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 China Therapeutic Vaccines Market - Industry Life Cycle |
3.4 China Therapeutic Vaccines Market - Porter's Five Forces |
3.5 China Therapeutic Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Therapeutic Vaccines Market Revenues & Volume Share, By Therapeutic Vaccines, 2021 & 2031F |
4 China Therapeutic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in China leading to a higher demand for therapeutic vaccines. |
4.2.2 Government initiatives to promote vaccination programs and improve healthcare infrastructure. |
4.2.3 Growing focus on preventive healthcare measures and a shift towards personalized medicine in the healthcare sector. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and lengthy approval processes for therapeutic vaccines in China. |
4.3.2 High research and development costs associated with developing new vaccines. |
4.3.3 Limited awareness and acceptance of therapeutic vaccines among the Chinese population. |
5 China Therapeutic Vaccines Market Trends |
6 China Therapeutic Vaccines Market, By Types |
6.1 China Therapeutic Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Therapeutic Vaccines Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Therapeutic Vaccines Market Revenues & Volume, By Peptide Therapeutic Vaccine, 2021- 2031F |
6.1.4 China Therapeutic Vaccines Market Revenues & Volume, By Cell Therapeutic Vaccine, 2021- 2031F |
6.1.5 China Therapeutic Vaccines Market Revenues & Volume, By Nucleic Acid Therapeutic Vaccine, 2021- 2031F |
6.2 China Therapeutic Vaccines Market, By Therapeutic Vaccines |
6.2.1 Overview and Analysis |
6.2.2 China Therapeutic Vaccines Market Revenues & Volume, By Oncotherapy, 2021- 2031F |
6.2.3 China Therapeutic Vaccines Market Revenues & Volume, By Hepatitis B, 2021- 2031F |
6.2.4 China Therapeutic Vaccines Market Revenues & Volume, By Tuberculosis, 2021- 2031F |
6.2.5 China Therapeutic Vaccines Market Revenues & Volume, By Herpes Simplex Virus, 2021- 2031F |
6.2.6 China Therapeutic Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
7 China Therapeutic Vaccines Market Import-Export Trade Statistics |
7.1 China Therapeutic Vaccines Market Export to Major Countries |
7.2 China Therapeutic Vaccines Market Imports from Major Countries |
8 China Therapeutic Vaccines Market Key Performance Indicators |
8.1 Number of new therapeutic vaccines introduced to the market. |
8.2 Percentage increase in vaccination coverage rates in China. |
8.3 Research and development investment in therapeutic vaccines. |
8.4 Number of partnerships and collaborations between pharmaceutical companies and research institutions for vaccine development. |
8.5 Adoption rate of therapeutic vaccines among healthcare providers and patients in China. |
9 China Therapeutic Vaccines Market - Opportunity Assessment |
9.1 China Therapeutic Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Therapeutic Vaccines Market Opportunity Assessment, By Therapeutic Vaccines, 2021 & 2031F |
10 China Therapeutic Vaccines Market - Competitive Landscape |
10.1 China Therapeutic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 China Therapeutic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here